- $700.35m
- $970.25m
- $893.40m
- 86
- 81
- 35
- 76
2019 September 27th | 2020 October 2nd | 2021 October 1st | 2022 September 30th | 2023 September 29th | |
---|---|---|---|---|---|
Period Length: | 52 W | 53 W | 52 W | 52 W | 52 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 781 | 738 | 818 | 859 | 893 |
Cost of Revenue | |||||
Gross Profit | 257 | 194 | 272 | 284 | 290 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 735 | 775 | 744 | 771 | 833 |
Operating Profit | 45.7 | -36.4 | 74.1 | 88.2 | 60.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 21.5 | -72.6 | 28.6 | 44.5 | 31.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 15.8 | -57.4 | 17.9 | 30.8 | 48.7 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 15.5 | -57.9 | 17.4 | 30.3 | 48.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 15.5 | -57.9 | 17.4 | 30.3 | 48.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.493 | -1.17 | 0.447 | 0.79 | 1.17 |